.. don't get this post wrong I am talking longer rather than short term, and who knows the share price may pull back further in the short term..
but
current market cap is $350M. they are scheduled to sell between 10-15k dose of illumet in 2019. assuming (and that is always a big if) they get FDA approval at some point and even sell 20000 doses at $3000 per dose then that is $60M revenue. for a p/e of 50 (which is not unheard of for a company that is expected to have strong growth) the current market cap requires $7M earnings (profit).
and that is only for illumet, not the other programs..
I stand by this company being a multi $B market cap within a few years.
obviously there are a lot of ifs in the above.. dyor
just my 2 cents
why I like telix
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.73 |
Change
0.100(0.48%) |
Mkt cap ! $6.937B | |||
| Open | High | Low | Value | Volume |
| $20.83 | $20.99 | $20.40 | $17.24M | 830.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $20.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.74 | 16468 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |